+Search query
-Structure paper
Title | Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*. |
---|---|
Journal, issue, pages | Angew. Chem. Int. Ed. Engl., Vol. 60, Page 17131-17137, Year 2021 |
Publish date | Jun 16, 2020 (structure data deposition date) |
![]() | Quach, D. / Tang, G. / Anantharajan, J. / Baburajendran, N. / Poulsen, A. / Wee, J.L.K. / Retna, P. / Li, R. / Liu, B. / Tee, D.H.Y. ...Quach, D. / Tang, G. / Anantharajan, J. / Baburajendran, N. / Poulsen, A. / Wee, J.L.K. / Retna, P. / Li, R. / Liu, B. / Tee, D.H.Y. / Kwek, P.Z. / Joy, J.K. / Yang, W.Q. / Zhang, C.J. / Foo, K. / Keller, T.H. / Yao, S.Q. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 2.3 - 2.723 Å |
Structure data | ![]() PDB-7cc2: ![]() PDB-7dt2: |
Chemicals | ![]() ChemComp-FVC: ![]() ChemComp-HOH: ![]() ChemComp-HJ9: |
Source |
|
![]() | TRANSFERASE / Tyrosine kinase Covalent inhibitor chronic myelogenous leukemia |